...
首页> 外文期刊>American journal of public health >Herpes Zoster and Exposure to the Varicella Zoster Virus in an Era of Varicella Vaccination
【24h】

Herpes Zoster and Exposure to the Varicella Zoster Virus in an Era of Varicella Vaccination

机译:水痘疫苗接种时代的带状疱疹和水痘带状疱疹病毒的暴露

获取原文
           

摘要

Objectives. We performed a case–control study to determine if participants with herpes zoster had fewer contacts with persons with varicella or zoster, and with young children, to explore the hypothesis that exposure to persons with varicella zoster virus (VZV) results in “immune boosting.” Methods. Participants were patients of the multispecialty Marshfield Clinic in Wisconsin. We identified patients aged 40 to 79 years with a new diagnosis of zoster from August 2000 to July 2005. We frequency matched control participants to case participants for age. We confirmed diagnoses by chart review and assessed exposures by interview. Results. Interviews were completed by 633 of 902 eligible case participants (70.2%) and 655 of 1149 control participants (57.0%). The number of varicella contacts was not associated with zoster; there was no trend even at the highest exposure level (3 or more contacts). Similarly, there was no association with exposure to persons with zoster or to children, or with workplace exposures. Conclusions. Although exposure to VZV in our study was relatively low, the absence of a relationship with zoster reflects the uncertain influence of varicella circulation on zoster epidemiology. Herpes zoster, also known as shingles, is a condition caused by reactivation of the latent varicella zoster virus (VZV), which lies dormant in sensory ganglia after primary infection (i.e., chickenpox). 1 Clinically, the condition is usually characterized by a painful vesicular rash in a dermatomal pattern. A summary of several investigations estimates the annual number of zoster cases at 1 million after age adjustment to the 2000 US population. 2 Although the factors that allow virus reactivation in healthy individuals are not completely understood, it is believed that a decline in cell-mediated immunity plays a pivotal role. 3 , 4 Since licensure of the varicella vaccine in 1995, there has been a dramatic decline in the number of chickenpox cases in the United States. 5 However, there is concern that the relative absence of VZV circulating in the population may result in reduced immune boosting and an increase in the incidence of zoster. 6 , 7 Evidence to support this hypothesis was provided by a case–control study in the United Kingdom that found that contacts in the previous 10 years with varicella and with children reduced the risk of zoster. 8 We describe a case–control study to test the hypothesis that persons with zoster have fewer contacts with persons with varicella or zoster, and fewer contacts with young children, compared with persons without zoster. The latter exposure is included because varicella is infectious before onset of the rash, 9 and because some varicella probably occurs among vaccinated children. These breakthrough cases are relatively mild and the diagnosis may be delayed or missed entirely. 10 , 11 .
机译:目标。我们进行了一项病例对照研究,以确定患有带状疱疹的参与者与水痘或带状疱疹患者以及与儿童的接触较少,以探讨假说暴露于水痘带状疱疹病毒(VZV)患者会导致“免疫增强”。 ”方法。参加者是威斯康星州马什菲尔德专科医院的患者。我们从2000年8月至2005年7月确定了40到79岁的带状疱疹的新诊断患者。我们将对照参与者与病例参与者的年龄相匹配。我们通过图表检查确认诊断,并通过访谈评估暴露情况。结果。访谈由902名合格案例参与者中的633名(70.2%)和1149名对照参与者中的655名(57.0%)完成。水痘接触的数量与带状疱疹无关。即使在最高暴露水平(3个或更多接触)下也没有趋势。同样,与带状疱疹或儿童接触或与工作场所接触均无关。结论。尽管在我们的研究中暴露于VZV的风险相对较低,但与带状疱疹的关系缺乏反映了水痘循环对带状疱疹流行病学的不确定影响。带状疱疹,也称为带状疱疹,是由潜伏性水痘带状疱疹病毒(VZV)重新激活引起的,该病毒在原发感染(即水痘)后潜伏在感觉神经节中。 1 临床上,病状通常以皮肤模式的痛性水疱疹为特征。几项调查的摘要估计,年龄调整后的2000年美国人口每年带状疱疹病例为100万。 2 尽管尚未完全理解健康个体中允许病毒重新激活的因素,但据信 3,4 自从1995年水痘疫苗获得许可以来,美国水痘病例的数量急剧下降。 sup> 5 然而,令人担忧的是,人群中相对缺乏VZV循环可能会导致免疫力下降和带状疱疹的发生率增加。 6,7 支持的证据该假设由英国的病例对照研究提供,该研究发现在过去10年中与水痘和儿童接触减少了带状疱疹的风险。 8 我们将病例对照研究描述为测试带状疱疹患者的假说与没有带状疱疹的人相比,与水痘或带状疱疹的人接触较少,与幼儿的接触较少。之所以包括后者,是因为水疱在皮疹发作之前具有传染性, 9 ,并且因为接种疫苗的儿童中可能会出现一些水痘。这些突破性病例相对较轻,诊断可能会延迟或完全漏诊。 10,11

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号